# Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

> **NCT04216693** · PHASE2 · WITHDRAWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School**

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Digoxin tablet
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04216693
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative decision to terminate.
- **Last updated:** 2023-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04216693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04216693, "Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04216693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*